Stakeholders of Theranostics

Dr. Richard Zimmermann is a distinguished figure in the field of nuclear medicine and radiopharmaceuticals. With a strong academic foundation, he holds MSc degrees in organic chemistry, physical chemistry, and molecular pharmacology, and a PhD in organic chemistry from the University of Strasbourg,

Authors

Institutions

Publication Details

Journal
Journal of Nuclear Medicine
Published
2025-04-24
DOI
https://doi.org/10.2967/jnumed.125.270085
Citations
1
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
3.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stakeholders of Theranostics

Richard Zimmermann, Thomas Beyer
1 citations
Journal of Nuclear Medicine
Health Systems, Economic Evaluations, Quality of Life
3.13
article

Stakeholders of Theranostics

Richard Zimmermann, Thomas Beyer
article en
1 citations

Abstract

Dr. Richard Zimmermann is a distinguished figure in the field of nuclear medicine and radiopharmaceuticals. With a strong academic foundation, he holds MSc degrees in organic chemistry, physical chemistry, and molecular pharmacology, and a PhD in organic chemistry from the University of Strasbourg,

Journal of Nuclear MedicineVol. 66(6)
Plastic Omnium (France) (FR), Medical University of Vienna (AT)
Openalex Percentile: Top 9%
Health Systems, Economic Evaluations, Quality of Life
3.13
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.